misonidazole has been researched along with EHS Tumor in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 64 (85.33) | 18.7374 |
1990's | 11 (14.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, GE; Cole, S; Fielden, EM; Naylor, MA; O'Neill, P; Stephens, MA; Stratford, IJ; Threadgill, MD; Webb, P | 1 |
Mulcahy, RT; Siemann, DW; Sutherland, RM | 2 |
Twentyman, PR | 1 |
McNally, NJ | 1 |
Denekamp, J; Rojas, A; Stewart, FA | 1 |
Denekamp, J; Rojas, A | 1 |
Brown, DM; Brown, JM; Lee, WW; Yu, NY | 1 |
Siemann, DW | 4 |
Brown, JM; Evans, JW; Horsman, MR | 1 |
Hill, SA; Keng, PC; Siemann, DW | 1 |
Bauer, KD; Hill, SA; Keng, PC; Siemann, DW | 1 |
Hill, SA; Siemann, DW | 2 |
Maddison, K; Siemann, DW; Wolf, K | 1 |
Grdina, DJ; Milas, L; Thames, HD | 1 |
Lee, FY; Workman, P | 2 |
Alvarez, R; Burgos, S; Correa, JN; Figueroa, A; Guzman, P; Infante, GA; Lanier, LJ; Myers, JA; Vera, J; Williams, TM | 1 |
Meyn, RE; Murray, D | 1 |
Morrissey, S; Siemann, DW; Wolf, K | 1 |
Baer, K; Chapman, JD; Lee, J | 1 |
Twentyman, PR; Workman, P | 1 |
de Ronde, J; Hinchliffe, M; McNally, NJ | 1 |
Mulcahy, RT; Siemann, DW | 1 |
Brown, JM; Twentyman, PR; Zamvil, SS | 1 |
Goldfeder, A | 1 |
Crabtree, KE; Curtis, SB; Flynn, MJ; Howard, J; Lyman, JT; Parr, SS; Tenforde, SD; Tenforde, TS | 1 |
Twentyman, P; Workman, P | 1 |
Brown, JM; Hirst, DG | 1 |
Denekamp, J; Hill, SA | 1 |
Reinhold, HS; van den Berg-Blok, A | 1 |
Chin, JB; Rauth, AM | 1 |
Kochanski, K; Siemann, DW | 1 |
Chapman, JD; Franko, AJ; Sharplin, J | 1 |
De Ronde, J; Martin, WM; McNally, NJ | 1 |
Brown, JM; Hirst, DG; Law, MP | 1 |
Grimmett, EV; Hofer, KG; Lehr, JE; MacKinnon, AR; Schubert, AL | 1 |
Denekamp, J; Hirst, DG; Stewart, FA; Terry, NH | 1 |
Grdina, DJ; Jovonovich, JA; Sigdestad, CP | 1 |
Tannock, IF | 2 |
Adams, GE; Bradley, JK; Bremner, JC; Naylor, MA; Sansom, JM; Stratford, IJ | 1 |
Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
Deys, BF; Stap, J | 1 |
Brown, JM | 1 |
Siemann, DW; Sutherland, RM | 1 |
Adams, GE; Cole, S; Elliott, W; Fielden, EM; Leopold, W; Sebolt-Leopold, J; Stratford, IJ; Suto, M | 1 |
Binger, M; Workman, P | 1 |
Adams, GE; Bowler, J; Cole, S; Lorimore, SA; Nolan, J; Stratford, IJ; Wright, EG | 1 |
Hunter, N; Ito, H; Milas, L; Nakayama, T | 1 |
Adams, GE; Bowler, J; Bremner, JC; Stratford, IJ | 1 |
Adams, GE; Cole, S; Fielden, EM; Jenkins, TC; Stratford, IJ | 1 |
Herman, TS; Holden, SA; Jones, SM; Teicher, BA | 1 |
Deacon, J; Holliday, S; Stratford, IJ; Walling, JM | 1 |
Herman, TS; Kaufmann, M; Teicher, BA | 1 |
Gulyas, S; Hill, RP; Whitmore, GF | 1 |
Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
Grierson, JR; Grunbaum, Z; Koh, WJ; Krohn, KA; Rasey, JS | 1 |
Hunter, N; Milas, L; Peters, LJ | 1 |
Hofer, KG; Hofer, MG; Lakkis, M | 1 |
Adams, GE; Godden, J; Howells, N; Nolan, J; Stratford, IJ; Timpson, N | 1 |
Murray, JC; Randhawa, VS | 1 |
Allalunis-Turner, MJ; Siemann, DW | 1 |
Gipp, JJ; Mulcahy, RT; Tanner, MA | 1 |
Denekamp, J; Murray, JC; Randhawa, V | 1 |
Dynlacht, J; Friedland, JL; Hofer, KG; Hofer, MG | 1 |
Durand, RE; Grunbaum, Z; Krohn, KA; Magee, S; Nelson, NJ; Olive, PL; Rasey, JS | 1 |
Chaplin, DJ; Durand, RE | 1 |
Workman, P | 1 |
Alliet, KL; Siemann, DW | 1 |
Hill, SA; Keng, PC; Maddison, K; Siemann, DW; Wolf, K | 1 |
75 other study(ies) available for misonidazole and EHS Tumor
Article | Year |
---|---|
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Mice; Nitro Compounds; Radiation-Sensitizing Agents; Sarcoma, Experimental; Structure-Activity Relationship; Thiophenes | 1991 |
Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Streptozocin | 1982 |
Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Topics: Amifostine; Animals; Body Weight; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukocyte Count; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental | 1981 |
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
Topics: Amifostine; Animals; Cell Survival; Cyclophosphamide; Drug Therapy, Combination; Leukopenia; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental | 1982 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance; Sarcoma, Experimental | 1983 |
Time dependence of interaction of misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental; Time Factors | 1983 |
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; X-Rays | 1981 |
Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Etanidazole; Female; Leukocyte Count; Lomustine; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1982 |
Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Topics: Animals; Body Temperature; Cell Survival; Drug Synergism; Female; Kinetics; Melphalan; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1984 |
Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
Topics: Animals; Cell Cycle; Cell Separation; Cell Survival; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1984 |
The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
Topics: Animals; Cell Cycle; DNA, Neoplasm; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; RNA, Neoplasm; Sarcoma, Experimental | 1984 |
Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Topics: Animals; Combined Modality Therapy; Drug Synergism; Drug Therapy, Combination; Female; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1984 |
Chemopotentiation in vivo: no loss of sensitization with fractionation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Leukocyte Count; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Sarcoma, Experimental | 1984 |
Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Topics: Animals; Aziridines; Azirines; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1984 |
Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Sarcoma, Experimental; Tumor Stem Cell Assay | 1984 |
Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Topics: Animals; Bone Marrow; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Intestine, Small; Kinetics; Lomustine; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1984 |
Radiosensitization by derivatives of isoindole-4,7-dione.
Topics: Animals; Chemical Phenomena; Chemistry; Indoles; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Pulse Radiolysis; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1984 |
Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
Topics: Animals; Cross-Linking Reagents; DNA; DNA Repair; DNA, Neoplasm; Fibrosarcoma; Glutathione; Jejunum; Maleates; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Spleen | 1983 |
In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1983 |
Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
Topics: Anaerobiosis; Animals; Binding, Competitive; Cell Line; Cricetinae; Cricetulus; Fibrosarcoma; Kidney; Kinetics; Mice; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Temperature | 1983 |
Chemosensitization by lipophilic nitroimidazoles.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukocyte Count; Lomustine; Male; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1983 |
Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
Topics: Animals; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Leukopenia; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1983 |
In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Topics: Animals; Carmustine; Cell Line; Drug Resistance; Drug Synergism; Humans; Leukemia L1210; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Sarcoma, Experimental | 1983 |
Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cytotoxicity, Immunologic; Female; Immunotherapy; Macrophages; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Radiation-Induced; Sarcoma, Experimental | 1980 |
Cell kinetics, cell structure, and radiotherapy.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Computers; Female; Hot Temperature; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Microscopy, Electron; Misonidazole; Sarcoma, Experimental | 1982 |
Misonidazole enhancement of radiation-induced growth delay in rat rhabdomyosarcoma tumours exposed to accelerated carbon and neon ions.
Topics: Animals; Carbon; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Nitroimidazoles; Particle Accelerators; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Sarcoma, Experimental | 1981 |
Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Lethal Dose 50; Leukocyte Count; Lomustine; Male; Melphalan; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1982 |
Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Topics: Animals; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Lethal Dose 50; Leukocyte Count; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1982 |
Site dependent response of tumours to combined heat and radiation.
Topics: Animals; Dose-Response Relationship, Radiation; Foot; Hindlimb; Hot Temperature; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Regional Blood Flow; Sarcoma, Experimental; Soft Tissue Neoplasms; Tail; Temperature; Thorax | 1982 |
Enhancement of thermal damage to the microcirculation of 'sandwich' tumours by additional treatment.
Topics: Animals; Glucose; Hot Temperature; Microcirculation; Misonidazole; Radiation-Sensitizing Agents; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Sarcoma, Experimental; Time Factors | 1981 |
In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Lomustine; Mice; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Sarcoma, Experimental; Time Factors | 1981 |
The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
Topics: Animals; Autoradiography; Chromatography, Paper; Kinetics; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Polarography; Sarcoma, Experimental; Time Factors; Tissue Distribution | 1981 |
Combinations of radiation and misonidazole in a murine lung tumor model.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Female; Lung; Lung Neoplasms; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radiotherapy; Sarcoma, Experimental; Time Factors | 1981 |
A marker for hypoxic cells in tumours with potential clinical applicability.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Cells, Cultured; Cricetinae; Fibrosarcoma; Mice; Mice, Inbred BALB C; Misonidazole; Oxygen Consumption; Sarcoma, Experimental | 1981 |
Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Topics: Animals; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; In Vitro Techniques; Melphalan; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Urination | 1981 |
Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Topics: Animals; Cell Line; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Hematopoietic Stem Cells; Leukocytes; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1981 |
Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat.
Topics: Animals; Bone Marrow; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Female; Hot Temperature; Intestinal Mucosa; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Mice, Inbred ICR; Misonidazole; Nitroimidazoles; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Skin | 1981 |
Is tumour radiosensitization by misonidazole a general phenomenon?
Topics: Animals; Carcinoma; Cell Line; Dose-Response Relationship, Radiation; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Time Factors | 1980 |
The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
Topics: Animals; Carmustine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1981 |
Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT).
Topics: Animals; Antineoplastic Agents; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Nitroimidazoles; Photochemotherapy; Sarcoma, Experimental | 1994 |
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Influence of the hypoxic cell sensitizer misonidazole on the proliferation of well-oxygenated cells in vitro during prolonged exposure.
Topics: Animals; Cell Cycle; Cell Division; Cell Line; Hypoxia; Mice; Misonidazole; Mitosis; Nitroimidazoles; Osteosarcoma; Oxygen; Sarcoma, Experimental; Time Factors | 1979 |
Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.
Topics: Animals; Cell Survival; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Transplantation, Homologous | 1979 |
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured | 1992 |
Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Drug Evaluation; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1992 |
Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Female; Half-Life; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Sarcoma, Experimental | 1991 |
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Topics: Administration, Oral; Animals; Combined Modality Therapy; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1991 |
Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole.
Topics: Animals; Drug Therapy, Combination; Female; Indomethacin; Mice; Mice, Inbred C3H; Misonidazole; Radiation Tolerance; Sarcoma, Experimental | 1991 |
Bioreductive drugs and the selective induction of tumour hypoxia.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Constriction; Hydralazine; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Mitomycins; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tirapazamine; Triazines | 1990 |
Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cyclophosphamide; Drug Synergism; Female; Hydralazine; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Sarcoma, Experimental; Stem Cells | 1990 |
Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Topics: Animals; Antineoplastic Agents; Female; Mice; Mice, Inbred C3H; Misonidazole; Prodrugs; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1990 |
Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Drug Combinations; Etanidazole; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
High uptake of RSU 1069 and its analogues melanotic melanomas.
Topics: Animals; Cell Line; Cell Membrane Permeability; Deoxyribonucleases; Drug Evaluation, Preclinical; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred Strains; Microbial Collagenase; Misonidazole; Sarcoma, Experimental; Tissue Distribution; Trypsin; Tumor Cells, Cultured | 1989 |
Platinum complexes of triaminotriphenylmethanes: interaction with DNA and radiosensitization.
Topics: Animals; Cell Hypoxia; Cell Survival; DNA; Dose-Response Relationship, Drug; Fibrosarcoma; Male; Methyl Green; Mice; Mice, Inbred C3H; Misonidazole; Molecular Conformation; Neoplasm Transplantation; Organoplatinum Compounds; Radiation-Sensitizing Agents; Rosaniline Dyes; Sarcoma, Experimental; Tumor Cells, Cultured | 1989 |
Toxicity of RSU-1069 for KHT cells treated in vivo or in vitro: evidence for a diffusible toxic product.
Topics: Animals; Cell Count; Cell Survival; Diffusion; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured | 1989 |
The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Synergism; Lomustine; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Hypoxia; Cells, Cultured; Contrast Media; Cricetinae; Cricetulus; Dogs; Fibroblasts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Osteosarcoma; Radiation Tolerance; Radionuclide Imaging; Sarcoma, Experimental | 1989 |
Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction.
Topics: Aerobiosis; Anaerobiosis; Animals; Extremities; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiation Tolerance; Sarcoma, Experimental | 1989 |
Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
Topics: Animals; Combined Modality Therapy; Female; Hyperthermia, Induced; Iodine Radioisotopes; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured | 1989 |
Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hydralazine; Male; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Oxygen Consumption; Sarcoma, Experimental; Time Factors | 1988 |
Misonidazole reduces blood flow in two experimental murine tumours.
Topics: Animals; Blood Volume; Carcinoma; Depression, Chemical; Kidney; Mice; Mice, Inbred Strains; Misonidazole; Muscles; Regional Blood Flow; Sarcoma, Experimental; Skin; Time Factors | 1988 |
Potentiation of combination chemotherapy by nitroheterocyclics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Synergism; Female; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1988 |
Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
Topics: Aerobiosis; Animals; Cell Line; Combined Modality Therapy; Drug Synergism; Female; Hot Temperature; Hyperthermia, Induced; Lomustine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Sarcoma, Experimental | 1987 |
The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Benzimidazoles; Blood Vessels; Fluorescent Antibody Technique; Fluorescent Dyes; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Sarcoma, Experimental | 1987 |
Radiosensitizing and cytocidal effects of misonidazole: evidence for separate modes of action.
Topics: Animals; Cell Cycle; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Idoxuridine; Mathematics; Mice; Misonidazole; Radiation Tolerance; Sarcoma, Experimental | 1987 |
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
Topics: Animals; Autoradiography; Biotransformation; Carbon Radioisotopes; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Hypoxia; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Radionuclide Imaging; Sarcoma, Experimental; Tritium | 1987 |
Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
Topics: Animals; Cell Line; Cell Separation; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Humans; Lomustine; Misonidazole; Sarcoma, Experimental | 1987 |
Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards.
Topics: Animals; Blood Proteins; Chromatography, High Pressure Liquid; Drug Interactions; Hydrolysis; Kinetics; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitrogen Mustard Compounds; Nitroimidazoles; Protein Binding; Sarcoma, Experimental | 1986 |
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069.
Topics: Animals; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1986 |
Combinations of CCNU, MISO, and fractionated radiotherapy.
Topics: Animals; Combined Modality Therapy; Lomustine; Mice; Misonidazole; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sarcoma, Experimental | 1986 |
In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Topics: Animals; Combined Modality Therapy; Female; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Tumor Stem Cell Assay | 1985 |